Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

By Disis M.L.   Knutson K.L.   Schiffman K.   Rinn K.   McNeel D.G.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 3, 2000-08 ,pp. : 245-252

Springer Publishing Company

Access to resources Recommend Favorite

Anti-idiotype responses abrogate anti-CD4–induced tolerance to a tumor-specific antigen and promote systemic tumor immunity

By Kennedy Ronald   Shearer Michael   Lowe Devin   Jumper Cynthia   Chiriva-Internati Maurizio   Bright Robert  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 987-994

Springer Publishing Company

Access to resources Recommend Favorite

Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma

By Bermont L.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 2, 2000-09 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis

By Khalid Sarah  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 647-659

Springer Publishing Company

Access to resources Recommend Favorite

MMP-9 increases HER2/neu expression and alters apoptosis levels in human mammary epithelial cells (HMEC)

By Fatunmbi Matilda  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 519-530

Springer Publishing Company

Access to resources Recommend Favorite